Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the fourth quarter of 2022.

In this edition, class actions gain an international flair, insurers have cures for COVID cases, and a remote presence is still a presence. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.

We wrap up the Roundup with a summary of class action settlements finalized in the fourth quarter.

Read the Roundup


Meet the Authors
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.